News reporting · JAMA · 2022-10-25
A clinical news update described a British test-and-treat study alongside a Norwegian trial of cod liver oil.
JAMA reported on two large trials carried out during the pandemic. In Britain, 6,200 people joined a study in which some participants were offered a blood test and vitamin D if their level was below the trial threshold. The offer produced no clear reduction in respiratory infections over six months.
In Norway, nearly 35,000 adults were assigned cod liver oil or placebo. The researchers also found no reduction in respiratory infections. The oil provided vitamin A and omega-3 fatty acids alongside vitamin D.
The British study tested daily doses of 800 or 3,200 IU for people whose blood vitamin D was below 75 nmol/L. The Norwegian trial took a different approach, giving adults a daily spoonful of cod liver oil or a placebo without first selecting them for low vitamin D.
